Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
0.979
-0.009 (-0.87%)
At close: Dec 20, 2024, 4:00 PM
1.060
+0.081 (8.32%)
After-hours: Dec 20, 2024, 7:12 PM EST
Opus Genetics Market Cap
Opus Genetics has a market cap or net worth of $30.89 million as of December 20, 2024. Its market cap has decreased by -51.78% in one year.
Market Cap
30.89M
Enterprise Value
-5.75M
1-Year Change
-51.78%
Ranking
Category
Stock Price
0.98
Market Cap Chart
Since November 6, 2020, Opus Genetics's market cap has increased from $21.26M to $30.89M, an increase of 45.28%. That is a compound annual growth rate of 9.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 30.89M | -54.67% |
| Dec 29, 2023 | 68.14M | -7.23% |
| Dec 30, 2022 | 73.45M | 13.82% |
| Dec 31, 2021 | 64.53M | -8.29% |
| Dec 31, 2020 | 70.36M | 230.93% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AEON Biopharma | 26.58M |
| LAVA Therapeutics | 26.56M |
| KALA BIO | 26.55M |
| Enlivex Therapeutics | 26.39M |
| DURECT | 26.21M |
| Lipocine | 25.35M |
| NextCure | 24.93M |
| Femasys | 24.73M |